CAI
Caris Life Sciences, Inc.
30.70$
+2.2%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.1% | +9.7% | +17.9% | +18.4% | +24.0% | -3.6% | -29.4% | -12.1% | +18.4% | +34.7% | +97.0% | |
| – | +16.2% | +58.7% | +26.7% | +14.2% | +22.0% | -1.1% | -49.1% | +62.5% | +21.5% | +7.7% | +16.9% | |
| – | +3.0% | -15.8% | +9.2% | +23.1% | +26.2% | -6.1% | -8.2% | -56.5% | +11.6% | +100.2% | +201.6% | |
| – | – | – | – | – | – | – | – | – | +15.4% | -2.5% | -60.2% | |
| – | – | – | +29.2% | +19.7% | +17.8% | +4.8% | -48.2% | +471.7% | -2.7% | +14.2% | +29.6% | |
| – | +19.8% | +9.9% | +23.7% | -11.1% | +1.9% | +8.3% | -35.8% | +778.1% | +3.3% | +6.6% | +13.3% | |
| – | -4.3% | -29.8% | -3.1% | +60.2% | +40.8% | -12.4% | +6.8% | -327.0% | – | – | – | |
| – | -2.2% | +2.3% | +18.6% | +24.1% | +47.7% | +1.0% | -22.2% | -56.7% | +18.5% | +58.3% | +13.6% | |
| – | -5.6% | -53.8% | -68.4% | +479.1% | +42.5% | -32.2% | -46.5% | -1,186.3% | – | – | – | |
| – | +1.9% | -40.9% | -9.6% | -486.6% | – | +45.2% | -57.1% | – | – | – | – | |
| – | -5.7% | -55.5% | -77.7% | +1,101.6% | +9.1% | -60.5% | -10.6% | -1,256.8% | – | – | – | |
| – | +3.5% | -0.1% | -12.2% | +40.3% | +26.8% | -12.4% | +2.5% | -196.6% | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.